{"database": "openregs", "table": "federal_register", "rows": [["2025-20658", "Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine; Public Workshop; Request for Comments", "Notice", "The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled \"Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine.\" The purpose of the public workshop is to initiate a discussion on expanding epinephrine accessibility and use, including in community settings, to reduce anaphylaxis-related morbidity and mortality. This public workshop will be convened and supported by a cooperative agreement between FDA and the Duke-Margolis Institute for Health Policy.", "2025-11-24", 2025, 11, "https://www.federalregister.gov/documents/2025/11/24/2025-20658/improving-anaphylaxis-outcomes-approaches-for-enhancing-access-to-epinephrine-public-workshop", "https://www.govinfo.gov/content/pkg/FR-2025-11-24/pdf/2025-20658.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public workshop entitled \"Improving Anaphylaxis Outcomes: Approaches for Enhancing Access to Epinephrine.\" The purpose of the public workshop is to initiate a...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2025-20658"], "units": {}, "query_ms": 306.733664998319, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}